Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study

Daniela Romualdi; Barbara Costantini; Giuseppe Campagna; Antonio Lanzone; Maurizio Guido

doi:10.1016/j.fertnstert.2007.09.020

Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study

Daniela Romualdi, Barbara Costantini, Giuseppe Campagna, Antonio Lanzone, Maurizio Guido

Risultato della ricerca: Contributo in rivista › Articolo

28 Citazioni (Scopus)

Abstract

To evaluate the effect of the soy isoflavone genistein on the metabolic and hormonal disturbances of polycystic ovary syndrome (PCOS), we studied a group of obese, hyperinsulinemic, and dyslipidemic women presenting this syndrome during 6 months of phytoestrogen administration.

Lingua originale	Inglese
pagine (da-a)	1826-1833
Numero di pagine	8
Rivista	Fertility and Sterility
Volume	90
DOI	https://doi.org/10.1016/j.fertnstert.2007.09.020
Stato di pubblicazione	Pubblicato - 2008

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

Keywords

Adolescent
Adult
Blood Glucose
Body Mass Index
Cholesterol
Dyslipidemias
Female
Genistein
Hormones
Humans
Hyperinsulinism
Insulin
Lipid Metabolism
Obesity
Phytoestrogens
Pilot Projects
Polycystic Ovary Syndrome
Prospective Studies
Time Factors
Treatment Outcome
Triglycerides
Waist-Hip Ratio
Young Adult

Accesso al documento

10.1016/j.fertnstert.2007.09.020

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{f1ae133cc27340f186fbf23147b21e52,

title = "Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study",

abstract = "To evaluate the effect of the soy isoflavone genistein on the metabolic and hormonal disturbances of polycystic ovary syndrome (PCOS), we studied a group of obese, hyperinsulinemic, and dyslipidemic women presenting this syndrome during 6 months of phytoestrogen administration.",

keywords = "Adolescent, Adult, Blood Glucose, Body Mass Index, Cholesterol, Dyslipidemias, Female, Genistein, Hormones, Humans, Hyperinsulinism, Insulin, Lipid Metabolism, Obesity, Phytoestrogens, Pilot Projects, Polycystic Ovary Syndrome, Prospective Studies, Time Factors, Treatment Outcome, Triglycerides, Waist-Hip Ratio, Young Adult, Adolescent, Adult, Blood Glucose, Body Mass Index, Cholesterol, Dyslipidemias, Female, Genistein, Hormones, Humans, Hyperinsulinism, Insulin, Lipid Metabolism, Obesity, Phytoestrogens, Pilot Projects, Polycystic Ovary Syndrome, Prospective Studies, Time Factors, Treatment Outcome, Triglycerides, Waist-Hip Ratio, Young Adult",

author = "Daniela Romualdi and Barbara Costantini and Giuseppe Campagna and Antonio Lanzone and Maurizio Guido",

year = "2008",

doi = "10.1016/j.fertnstert.2007.09.020",

language = "English",

volume = "90",

pages = "1826--1833",

journal = "Fertility and Sterility",

issn = "0015-0282",

publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study

AU - Romualdi, Daniela

AU - Costantini, Barbara

AU - Campagna, Giuseppe

AU - Lanzone, Antonio

AU - Guido, Maurizio

PY - 2008

Y1 - 2008

N2 - To evaluate the effect of the soy isoflavone genistein on the metabolic and hormonal disturbances of polycystic ovary syndrome (PCOS), we studied a group of obese, hyperinsulinemic, and dyslipidemic women presenting this syndrome during 6 months of phytoestrogen administration.

AB - To evaluate the effect of the soy isoflavone genistein on the metabolic and hormonal disturbances of polycystic ovary syndrome (PCOS), we studied a group of obese, hyperinsulinemic, and dyslipidemic women presenting this syndrome during 6 months of phytoestrogen administration.

KW - Adolescent

KW - Adult

KW - Blood Glucose

KW - Body Mass Index

KW - Cholesterol

KW - Dyslipidemias

KW - Female

KW - Genistein

KW - Hormones

KW - Humans

KW - Hyperinsulinism

KW - Insulin

KW - Lipid Metabolism

KW - Obesity

KW - Phytoestrogens

KW - Pilot Projects

KW - Polycystic Ovary Syndrome

KW - Prospective Studies

KW - Time Factors

KW - Treatment Outcome

KW - Triglycerides

KW - Waist-Hip Ratio

KW - Young Adult

KW - Adolescent

KW - Adult

KW - Blood Glucose

KW - Body Mass Index

KW - Cholesterol

KW - Dyslipidemias

KW - Female

KW - Genistein

KW - Hormones

KW - Humans

KW - Hyperinsulinism

KW - Insulin

KW - Lipid Metabolism

KW - Obesity

KW - Phytoestrogens

KW - Pilot Projects

KW - Polycystic Ovary Syndrome

KW - Prospective Studies

KW - Time Factors

KW - Treatment Outcome

KW - Triglycerides

KW - Waist-Hip Ratio

KW - Young Adult

UR - http://hdl.handle.net/10807/31763

U2 - 10.1016/j.fertnstert.2007.09.020

DO - 10.1016/j.fertnstert.2007.09.020

M3 - Article

SN - 0015-0282

VL - 90

SP - 1826

EP - 1833

JO - Fertility and Sterility

JF - Fertility and Sterility

ER -

Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study

Abstract

OSS delle Nazioni Unite

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo